US equities
|
MU
$888.09
▼-1.86%
NVDA
$214.14
▼-1.36%
AMZN
$261.83
▼-0.23%
SPCX
$143.65
▼-2.91%
TSLA
$366.44
▼-0.44%
AAPL
$341.43
▼-0.44%
SNDK
$1,348.84
▼-1.63%
META
$687.29
▼-2.57%
MU
$888.09
▼-1.86%
NVDA
$214.14
▼-1.36%
AMZN
$261.83
▼-0.23%
SPCX
$143.65
▼-2.91%
TSLA
$366.44
▼-0.44%
AAPL
$341.43
▼-0.44%
SNDK
$1,348.84
▼-1.63%
META
$687.29
▼-2.57%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Tools
My watchlist
My portfolio
Recent quotes
Articles published by BioLargo, Inc
BioLargo Subsidiary Clyra Medical to Exhibit at SAWC Fall 2026 in Las Vegas
October 13, 2026
From
BioLargo, Inc
Via
ACCESS Newswire
Tickers
BLGO
BioLargo Canada and Tu Nipi Form Indigenous-Led Partnership to Treat Oil Sands Process Water and More
September 10, 2026
From
BioLargo, Inc
Via
ACCESS Newswire
Tickers
BLGO
BioLargo Townhall and Q2 2026 Earnings Results Webcast and Conference Call on Thursday, September 10th, 2026 - 4:00 PM Eastern Time
September 09, 2026
From
BioLargo, Inc
Via
ACCESS Newswire
Tickers
BLGO
BioLargo's Subsidiary Clyra Medical Adds Third Distribution Channel Accelerating Commercial Rollout of ViaClyr Wound Irrigation Solution
September 03, 2026
From
BioLargo, Inc
Via
ACCESS Newswire
Tickers
BLGO
BioLargo to Participate in Gabelli Funds' 4th Annual PFAS Symposium in New York
August 25, 2026
From
BioLargo, Inc
Via
ACCESS Newswire
Tickers
BLGO
BioLargo Reports Second Quarter 2026 Results; Revenue Up 12% Sequentially, Gross Margin Expands to 54%
August 17, 2026
From
BioLargo, Inc
Via
ACCESS Newswire
Tickers
BLGO
BioLargo Joins New Jersey Institute of Technology-Led PFAS Consortium; President Tonya Chandler Appointed to Board of Directors
July 30, 2026
From
BioLargo, Inc
Via
ACCESS Newswire
Tickers
BLGO
BioLargo Equipment Solutions & Technologies' "PFAS Lady" to Teach PFAS 101 at 41st Annual Tri-State Seminar
July 29, 2026
From
BioLargo, Inc
Via
ACCESS Newswire
Tickers
BLGO
BioLargo PFAS Treatment Technology Featured in The Disruptive Quarterly
July 27, 2026
From
BioLargo, Inc
Via
ACCESS Newswire
Tickers
BLGO
BioLargo Relaunching CupriDyne(R)-Based Consumer Products - Back by Popular Demand and Generated More than $125 Million in Pet-Care Sales
July 13, 2026
From
BioLargo, Inc
Via
ACCESS Newswire
Tickers
BLGO
BioLargo Engineering Unit Awarded $1.4 Million in U.S. Air Force Environmental Contract Renewals
July 01, 2026
From
BioLargo, Inc
Via
ACCESS Newswire
Tickers
BLGO
